These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16128605)

  • 1. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors?
    Pascher A; Klupp J
    BioDrugs; 2005; 19(4):211-31. PubMed ID: 16128605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantation.
    Gerlach UA; Atanasov G; Wallenta L; Polenz D; Reutzel-Selke A; Kloepfel M; Jurisch A; Marksteiner M; Loddenkemper C; Neuhaus P; Sawitzki B; Pascher A
    Transplantation; 2014 Apr; 97(7):732-9. PubMed ID: 24598936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
    Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
    Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.
    Mehrabi A; Mood ZhA; Sadeghi M; Schmied BM; Müller SA; Welsch T; Kuttymuratov G; Wente MN; Weitz J; Zeier M; Morath Ch; Riediger C; Schemmer P; Encke J; Büchler MW; Schmidt J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii54-viii60. PubMed ID: 17890265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.
    Tragiannidis A; Kyriakidis I; Zündorf I; Groll AH
    Mycoses; 2017 Apr; 60(4):222-229. PubMed ID: 27766695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daclizumab: a review of its use in the management of organ transplantation.
    Carswell CI; Plosker GL; Wagstaff AJ
    BioDrugs; 2001; 15(11):745-73. PubMed ID: 11707149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat.
    Lin H; Chensue SW; Strieter RM; Remick DG; Gallagher KP; Bolling SF; Kunkel SL
    J Heart Lung Transplant; 1992; 11(2 Pt 1):330-5. PubMed ID: 1576139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A
    Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muromonab CD3. A review of its pharmacology and therapeutic potential.
    Todd PA; Brogden RN
    Drugs; 1989 Jun; 37(6):871-99. PubMed ID: 2503348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review.
    Toussirot E; Streit G; Wendling D
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):39-47. PubMed ID: 19075965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model.
    Heim C; Motsch B; Jalilova S; Bernhardt WM; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
    Transpl Immunol; 2016 Nov; 39():66-73. PubMed ID: 27590486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for heart transplantation-associated acute rejection, ischemia/reperfusion injury and coronary arteriosclerosis.
    Isobe M; Kosuge H; Koga N; Futamatsu H; Suzuki J
    Curr Gene Ther; 2004 Jun; 4(2):145-52. PubMed ID: 15180582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-alpha therapy for acute rejection in intestinal transplantation.
    Pascher A; Klupp J; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 Apr; 37(3):1635-6. PubMed ID: 15866693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.
    Garrouste C; Anglicheau D; Kamar N; Bachelier C; Rivalan J; Pereira B; Caillard S; Aniort J; Gatault P; Soubrier M; Sayegh J; Colosio C; Buisson A; Thervet E; Bouvier N; Heng AE
    Medicine (Baltimore); 2016 Oct; 95(41):e5108. PubMed ID: 27741127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
    Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
    [No Abstract]   [Full Text] [Related]  

  • 19. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation.
    Gerlach UA; Koch M; Müller HP; Veltzke-Schlieker W; Neuhaus P; Pascher A
    Am J Transplant; 2011 May; 11(5):1041-50. PubMed ID: 21521472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.